BrightGene
Suzhou · Founded 2001
About BrightGene
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.
Company Facts
- Founded: 2001
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $1M – $10M
- Total funding: $80.3M
- Funding stage: IPO
- Last round: Series Unknown (Jan 2019)
- Ticker: sse:688166
- Website: http://www.bright-gene.com/
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/brightgene-227538 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.